Department of Psychological & Brain Sciences, University of Iowa, Iowa City, Iowa.
Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, IA.
Ann Behav Med. 2019 Aug 16;53(9):816-826. doi: 10.1093/abm/kay091.
Patients approaching end-stage renal disease (ESRD) experience a high level of decisional conflict because they are often not provided with sufficient support and information regarding different treatment options prior to renal failure. Decisional conflict is an important correlate of treatment satisfaction, as it is associated with disease- and treatment-related knowledge that can inform decision-making. Patient activation, the willingness and ability to independently manage one's own health and healthcare, is an individual difference factor that may have important mitigating effects on decisional conflict.
To identify modifiable factors that may enhance the decision-making process in patients approaching ESRD by exploring potential mediational effects between decisional conflict, treatment satisfaction, and patient activation.
Sixty-four patients approaching ESRD completed self-report measures (32% response rate). Measures included the Decisional Conflict Scale, the Kidney Disease Treatment Questionnaire, and the Patient Activation Measure Short Form.
There was a high level of self-reported decisional conflict in this sample. Linear regressions revealed main effects among treatment satisfaction, patient activation, and decisional conflict. These variables were entered into PROCESS to assess a mediational pattern. Results showed that higher chronic kidney disease-related treatment satisfaction predicted lower decisional conflict through higher patient activation in a statistical mediational relationship.
While the link between treatment satisfaction and decision-making is well established, these results suggest this relationship might be partially explained by patient activation, a potentially modifiable process in patients approaching ESRD. Therefore, interventions that encourage patients to become actively involved in their care could also reduce decisional conflict among patients approaching ESRD.
接近终末期肾病(ESRD)的患者会经历高度的决策冲突,因为他们在肾衰竭之前通常没有得到足够的支持和关于不同治疗方案的信息。决策冲突是治疗满意度的一个重要相关因素,因为它与疾病和治疗相关的知识有关,可以为决策提供信息。患者激活是指愿意和能够独立管理自己的健康和医疗保健的意愿和能力,是一个个体差异因素,可能对决策冲突有重要的缓解作用。
通过探索决策冲突、治疗满意度和患者激活之间的潜在中介效应,确定可能增强接近 ESRD 患者决策过程的可调节因素。
64 名接近 ESRD 的患者完成了自我报告的测量(响应率为 32%)。测量包括决策冲突量表、肾病治疗问卷和患者激活量表简短版。
该样本中报告的决策冲突水平很高。线性回归显示了治疗满意度、患者激活和决策冲突之间的主要效应。这些变量被输入 PROCESS 以评估中介模式。结果表明,更高的慢性肾脏病相关治疗满意度通过更高的患者激活预测更低的决策冲突,这在统计中介关系中得到了体现。
虽然治疗满意度和决策之间的联系已经得到了很好的证实,但这些结果表明,这种关系可能部分可以通过患者激活来解释,这是接近 ESRD 的患者中一个潜在可调节的过程。因此,鼓励患者积极参与护理的干预措施也可以减少接近 ESRD 的患者的决策冲突。